This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Prolong Pharmaceuticals, LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations in Hemoglobin Compositions by Friedericke Kazo
Introduction
Friedericke Kazo is an accomplished inventor based in New Ipswich, NH (US). She has made significant contributions to the field of medical science, particularly in the development of hemoglobin compositions. With a total of two patents to her name, her work focuses on enhancing oxygen delivery in medical applications.
Latest Patents
Kazo's latest patents revolve around PEGylated hemoglobin compositions. These inventions provide formulations that contain hemoglobin capable of transferring oxygen or carbon monoxide to tissues in proximity. The PEGylated hemoglobin molecules are designed to be virally inactivated, ensuring safety in medical use. The compositions can be formulated as hypo-, iso-, or hypertonic solutions, making them versatile for treating various diseases and injuries by improving tissue oxygenation.
Career Highlights
Friedericke Kazo is associated with Prolong Pharmaceuticals, LLC, where she continues to innovate in the field of hemoglobin research. Her work has the potential to significantly impact medical treatments and improve patient outcomes.
Collaborations
Kazo collaborates with notable colleagues, including Abraham Abuchowski and Glenn Kazo, who contribute to her research and development efforts.
Conclusion
Friedericke Kazo's innovative work in hemoglobin compositions showcases her dedication to advancing medical science. Her contributions are poised to enhance therapeutic options for patients in need of improved oxygenation solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile